Vicore Pharma Holding AB (OSTO:VICO) Total Assets : kr1,203.1 Mil (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Vicore Pharma Holding AB Total Assets?

Vicore Pharma Holding AB's Total Assets for the quarter that ended in Dec. 2024 was kr1,203.1 Mil.

During the past 12 months, Vicore Pharma Holding AB's average Total Assets Growth Rate was 210.30% per year. During the past 3 years, the average Total Assets Growth Rate was -16.20% per year. During the past 5 years, the average Total Assets Growth Rate was -19.80% per year. During the past 10 years, the average Total Assets Growth Rate was -2.50% per year.

During the past 12 years, Vicore Pharma Holding AB's highest 3-Year average Total Assets Growth Rate was 31.90%. The lowest was -44.30%. And the median was -0.10%.

Total Assets is connected with ROA %. Vicore Pharma Holding AB's annualized ROA % for the quarter that ended in Dec. 2024 was -41.78%. Total Assets is also linked to Revenue through Asset Turnover. Vicore Pharma Holding AB's Asset Turnover for the quarter that ended in Dec. 2024 was 0.01.

Vicore Pharma Holding AB Total Assets Historical Data

The historical data trend for Vicore Pharma Holding AB's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vicore Pharma Holding AB Total Assets Chart

Vicore Pharma Holding AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Assets

Get a 7-Day Free Trial

406.52

451.17

338.01

497.84

1,203.11

Vicore Pharma Holding AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Assets	Get a 7-Day Free Trial															497.84	540.66	478.73	406.90	1,203.11

Vicore Pharma Holding AB Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Vicore Pharma Holding AB's Total Assets for the fiscal year that ended in Dec. 2024 is calculated as

Total Assets	=	Total Equity (A: Dec. 2024 )	+	Total Liabilities (A: Dec. 2024 )
	=	1129.329	+	73.779
	=	1,203.1

Vicore Pharma Holding AB's Total Assets for the quarter that ended in Dec. 2024 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2024 )	+	Total Liabilities (Q: Dec. 2024 )
	=	1129.329	+	73.779
	=	1,203.1

Vicore Pharma Holding AB (OSTO:VICO) Total Assets Explanation

Total Assets is connected with ROA %.

Vicore Pharma Holding AB's annualized ROA % for the quarter that ended in Dec. 2024 is

ROA %	=	Net Income (Q: Dec. 2024 )	/	( (Total Assets (Q: Sep. 2024 )	+	Total Assets (Q: Dec. 2024 ))	/ count )
	=	-336.3	/	( (406.902	+	1203.108)	/ 2 )
	=	-336.3	/	805.005
	=	-41.78 %

Note: The Net Income data used here is four times the quarterly (Dec. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Vicore Pharma Holding AB's Asset Turnover for the quarter that ended in Dec. 2024 is

	Asset Turnover
=	Revenue (Q: Dec. 2024 )	/	( (Total Assets (Q: Sep. 2024 )	+	Total Assets (Q: Dec. 2024 ))	/ count )
=	5.103	/	( (406.902	+	1203.108)	/ 2 )
=	5.103	/	805.005
=	0.01

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Vicore Pharma Holding AB Total Assets Related Terms

Thank you for viewing the detailed overview of Vicore Pharma Holding AB's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Vicore Pharma Holding AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vicore Pharma Holding AB (OSTO:VICO) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

6Y4:Germany

Address

Kornhamnstorg 53, Stockholm, SWE, 111 27

Website

https://www.vicorepharma.com

Vicore Pharma Holding AB is as a clinical-stage pharmaceutical company focused on severe lung diseases. The company is establishing a portfolio in respiratory diseases, including idiopathic pulmonary fibrosis (IPF). Its C21 is a small molecule angiotensin II type 2 receptor agonist (ATRAG) currently in phase 2a development for IPF. The company also has an investigational medical device in clinical development namely, Almee which is a digital therapeutic leveraging cognitive behavioral therapy created to address the psychological impact of living with pulmonary fibrosis.

Vicore Pharma Holding AB Headlines

No Headlines